Soft tissue sarcoma presenting with metastatic disease
نویسندگان
چکیده
منابع مشابه
Soft tissue sarcoma metastatic to pleura
Malignant pleural effusion (MPE) is a common complication of advanced cancer. The presence of MPE eliminates the possibility of radical cancer treatment, but palliative care plays an important role for these patients. Chemical pleurodesis is one of the options to avoid development of recurrent pleural effusions and thus palliate symptoms (2). In order pleurodesis to be successful, MPE should be...
متن کاملSoft tissue sarcoma metastatic to pleura.
Almost all cancers can cause distant pleural metastases. However, pleural metastases of soft tissue sarcoma that constitute less than 1% of adult solid malignancy are extremely rare. It is very difficult to distinguish them form sarcomatous malignant mesothelioma on histopathological features. We report a 57 year-old man who presented to us with left chest pain and progressive dyspnea and was d...
متن کاملCirculating tumour-derived DNA in metastatic soft tissue sarcoma
Following treatment 40% of soft tissue sarcoma (STS) patients suffer disease recurrence. In certain cancers circulating cell free DNA (cfDNA) and circulating tumour-derived DNA (ctDNA) characteristics correlate closely with disease burden, making them exciting potential sources of biomarkers. Despite this, the circulating nucleic acid characteristics of only 2 STS patients have been reported to...
متن کاملSurgical treatment of metastatic pulmonary soft-tissue sarcoma.
The lung is the most frequent site of metastasis from soft-tissue sarcomas. Due to the relative resistance of sarcoma to either chemotherapy or radiotherapy, compared to other solid tumors, surgical management of pulmonary metastases has been a pivotal therapy in this disease. With decades of experience in numerous centers, criteria for patient selection have been ascertained and documented. We...
متن کاملSystemic management strategies for metastatic soft tissue sarcoma.
Soft tissue sarcomas are rare tumours in adults and therefore require a multidisciplinary approach for optimal management. In the metastatic setting, chemotherapy is the primary modality of therapy. Doxorubicin alone or in combination with ifosfamide or dacarbazine has been the backbone of therapy since the 1970s. There is considerable activity for gemcitabine and docetaxel in leiomyosarcoma an...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 2010
ISSN: 0008-543X
DOI: 10.1002/cncr.25418